Recursion Pharma
Presence
Recursion Pharma is one of the...
Recursion Pharma is a company listed under the stock ticker RXRX (US).
Acquisition, funding and merger involving Recursion Pharma.
- Recursion Pharma has just announced a $50 Million fundraising (posted on July 17 2023).
- Recursion Pharma has announced the acquisition of Cyclica (posted on May 12 2023).
Executives
View the org chart displaying its 62 main executives
Most searched biographies at Recursion Pharma
- Chris Gibson, Chief Executive Officer and Director
- Martin Chavez, Chairman of the Board
- Zavain Dar, Board Member
Popular executive movements at Recursion Pharma
- Najat Khan has joined the company as Director, Chief R&D Officer and Chief Commercial Officer (posted on April 17 2024).
Create your alert
to follow the executive moves at Recursion Pharma.
Pharmaceuticals
Recursion Pharma has 1,863 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).
Popular M&A news in Pharmaceuticals
- AstraZeneca has announced the acquisition of Fusion Pharma (posted on March 23 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (posted on March 19 2024).
- Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).
Popular contacts in Pharmaceuticals
News
Press releases by Recursion Pharma
- Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer | Recursion Pharmaceuticals, Inc.
- Recursion Announces Plans to Open New Office in London | Recursion Pharmaceuticals, Inc.
- Recursion to Host Public L(earnings) Call on February 27 | Recursion Pharmaceuticals, Inc.
- Recursion Announces Data Collaboration Deal with Tempus, Top 50 Supercomputer Ambition Powered by NVIDIA, and Updated Focus of Collaboration with Bayer to Precision Oncology | Recursion Pharmaceuticals, Inc.
- Press Releases | Recursion Pharmaceuticals, Inc.
- Press Releases | Recursion Pharmaceuticals, Inc.
- Recursion Partners with NVIDIA in Groundbreaking Collaboration
- Recursion Releases MolRec, a Compound Intelligence Tool for Drug Discovery, Alongside the Largest of Its Kind Open-Source Dataset During First R&D Day
- Recursion to Participate in Upcoming Investor Conferences
- Press
- View more press releases Close
Social media about Recursion Pharma
- Recursion Pharma on Wikipedia, Google News & Yahoo Finance
- Recursion Pharma on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Chris Gibson 
Call Recursion Pharma at +1 385...
